Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system
Common Misconceptions About BPC-157 and TB-500 BPC-157 and TB-500 are clinically proven recovery peptides Neither is clinically proven for recovery
Your goals, body composition, training history and full metabolic panel, including fasting glucose, HbA1c, fasting insulin, lipid panel, thyroid panel, IGF-1 and inflammatory markers, are reviewed before any prescription
In line with this dedication, we are thrilled to announce the addition of two groundbreaking therapies to our repertoire: peptides, including BPC-157, and decompression therapy
Your provider can give you a better idea of what to expect, but injections are typically given bi-weekly for about three months